Louis Theroux

At Melatech, we are committed to making a difference in healthcare by providing solutions that support healthcare professionals and improve patients’ treatment through optimized clinical workflows. We aim to create powerful synergistic effects between doctors and machines through a combination of domain knowledge, engineering, and design. Over a thousand clinicians are currently using our solutions to improve their proficiency and provide optimal skin cancer diagnostics for many thousand patients. Our goal is to help clinicians from all over the world reach their absolute capacity, ensuring the best possible treatment for patients across the globe.

FC is home to a community of 500+ talented founders, operators, and investors. Our vetted members have access to a build diverse private market investment portfolio (from Seed to Pre-IPO) and allows them to participate in investment opportunities traditionally reserved for the elite.

Valarian builds infrastructure for organisations operating in high-trust, high-stakes environments. Our core product, ACRA, is a secure, compartmentalised backbone designed to run and protect mission-critical applications — now proven at the edge in portable GPU clusters as well as in the cloud and on-premise. We developed ACRA when existing infrastructure failed to meet real-world risk — where segmentation breaks down, audit trails disappear, and lateral movement cannot be contained. Valarian is a UK-founded and UK-led company, and backed by leading defence and national security investors. We are a homegrown team with backgrounds across defence, secure communications, high-assurance systems, and enterprise software — engineers and operators who have worked in environments where a lost signal or a missed audit can carry real consequences. We design like users because we’ve been them.

At Melatech, we are committed to making a difference in healthcare by providing solutions that support healthcare professionals and improve patients’ treatment through optimized clinical workflows. We aim to create powerful synergistic effects between doctors and machines through a combination of domain knowledge, engineering, and design. Over a thousand clinicians are currently using our solutions to improve their proficiency and provide optimal skin cancer diagnostics for many thousand patients. Our goal is to help clinicians from all over the world reach their absolute capacity, ensuring the best possible treatment for patients across the globe.

Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations. Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S and manages an investment portfolio, with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, Principal and Planetary Health Investments teams, Novo Holdings invests in life science companies at all stages of development.

We are a SaaS b2b company, developing the most advanced and customizable scheduling platform specifically made for driving instructors mainly to save them loads of time but ultimately deliver a better service for their end customers.